AAAAAA
Results:
1-12
|
Results: 12
Authors:
Weigmann, H
Hartter, S
Maehrlein, S
Kiefer, W
Kramer, G
Dannhardt, G
Hiemke, C
Citation: H. Weigmann et al., Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography, J CHROMAT B, 759(1), 2001, pp. 63-71
Authors:
Hartter, S
Wang, XM
Weigmann, H
Friedberg, T
Arand, M
Oesch, F
Hiemke, C
Citation: S. Hartter et al., Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin, J CL PSYCH, 21(2), 2001, pp. 167-174
Authors:
Weigmann, H
Gerek, S
Zeisig, A
Muller, M
Hartter, S
Hiemke, C
Citation: H. Weigmann et al., Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: Evidence from a therapeutic drug monitoring service, THER DRUG M, 23(4), 2001, pp. 410-413
Authors:
Hartter, S
Weigmann, H
Hiemke, C
Citation: S. Hartter et al., Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection, J CHROMAT B, 740(1), 2000, pp. 135-140
Authors:
Weigmann, H
Hartter, S
Bagli, M
Hiemke, C
Citation: H. Weigmann et al., Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine, EUR NEUROPS, 10(5), 2000, pp. 401-405
Authors:
Hartter, S
Grozinger, M
Weigmann, H
Roschke, J
Hiemke, C
Citation: S. Hartter et al., Increased bioavailability of oral melatonin after fluvoxamine coadministration, CLIN PHARM, 67(1), 2000, pp. 1-6
Authors:
Ulrich, S
Kruggel, S
Weigmann, H
Hiemke, C
Citation: S. Ulrich et al., Fishing for a drug: solid-phase microextraction for the assay of clozapinein human plasma, J CHROMAT B, 731(2), 1999, pp. 231-240
Authors:
Weigmann, H
Hartter, S
Fischer, V
Dahmen, N
Hiemke, C
Citation: H. Weigmann et al., Distribution of clozapine and desmethylclozapine between blood and brain in rats, EUR NEUROPS, 9(3), 1999, pp. 253-256
Authors:
Schmitt, U
Dahmen, N
Fischer, V
Weigmann, H
Rao, ML
Reuss, S
Hiemke, C
Citation: U. Schmitt et al., Chronic oral haloperidol and clozapine in rats: A behavioral evaluation, NEUROPSYCHB, 39(2), 1999, pp. 86-91
Authors:
Szegedi, A
Anghelescu, I
Wiesner, J
Schlegel, S
Weigmann, H
Hartter, S
Hiemke, C
Wetzel, H
Citation: A. Szegedi et al., Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial, PHARMACOPS, 32(4), 1999, pp. 148-153
Authors:
Lammers, CH
Deuschle, M
Weigmann, H
Hartter, S
Hiemke, C
Heese, C
Heuser, I
Citation: Ch. Lammers et al., Coadministration of clozapine and fluvoxamine in psychotic patients - Clinical experience, PHARMACOPS, 32(2), 1999, pp. 76-77
Authors:
Anghelescu, I
Szegedi, A
Schlegel, S
Weigmann, H
Hiemke, C
Wetzel, H
Citation: I. Anghelescu et al., Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial, EUR NEUROPS, 8(4), 1998, pp. 315-320
Risultati:
1-12
|